1. Home
  2. AFL vs HLN Comparison

AFL vs HLN Comparison

Compare AFL & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFL
  • HLN
  • Stock Information
  • Founded
  • AFL 1955
  • HLN 2022
  • Country
  • AFL United States
  • HLN United Kingdom
  • Employees
  • AFL N/A
  • HLN N/A
  • Industry
  • AFL Accident &Health Insurance
  • HLN Package Goods/Cosmetics
  • Sector
  • AFL Finance
  • HLN Consumer Discretionary
  • Exchange
  • AFL Nasdaq
  • HLN Nasdaq
  • Market Cap
  • AFL 56.4B
  • HLN 48.2B
  • IPO Year
  • AFL N/A
  • HLN N/A
  • Fundamental
  • Price
  • AFL $108.52
  • HLN $9.85
  • Analyst Decision
  • AFL Hold
  • HLN Buy
  • Analyst Count
  • AFL 13
  • HLN 1
  • Target Price
  • AFL $109.15
  • HLN $10.95
  • AVG Volume (30 Days)
  • AFL 2.6M
  • HLN 8.1M
  • Earning Date
  • AFL 10-29-2025
  • HLN 07-31-2025
  • Dividend Yield
  • AFL 2.13%
  • HLN 1.82%
  • EPS Growth
  • AFL N/A
  • HLN 41.64
  • EPS
  • AFL 4.43
  • HLN 0.23
  • Revenue
  • AFL $15,910,000,000.00
  • HLN $15,096,588,575.00
  • Revenue This Year
  • AFL N/A
  • HLN $1.38
  • Revenue Next Year
  • AFL N/A
  • HLN $4.24
  • P/E Ratio
  • AFL $24.54
  • HLN $43.22
  • Revenue Growth
  • AFL N/A
  • HLN N/A
  • 52 Week Low
  • AFL $96.95
  • HLN $8.86
  • 52 Week High
  • AFL $115.50
  • HLN $11.42
  • Technical
  • Relative Strength Index (RSI)
  • AFL 59.91
  • HLN 53.87
  • Support Level
  • AFL $104.66
  • HLN $9.77
  • Resistance Level
  • AFL $108.75
  • HLN $9.93
  • Average True Range (ATR)
  • AFL 1.61
  • HLN 0.12
  • MACD
  • AFL -0.03
  • HLN 0.02
  • Stochastic Oscillator
  • AFL 89.86
  • HLN 72.84

About AFL AFLAC Incorporated

Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: